Researchers find master switch for adult epilepsy
June 27, 2011 in NeuroscienceUC Irvine and French researchers have identified a central switch responsible for the transformation of healthy brain cells into epileptic ones, opening the way to both treat and prevent temporal lobe epilepsy.
Epilepsy affects 1 to 2 percent of the world's population, and TLE is the most common form of the disorder in adults. Among adult neurologic conditions, only migraine headaches are more prevalent. TLE is resistant to treatment in 30 percent of cases.
UCI neurologist and neuroscientist Dr. Tallie Z. Baram and her colleagues found that TLE manifests after a major reorganization of the molecules governing the behavior of neurons, the cells that communicate within the brain. These alterations often stem from prolonged febrile seizures, brain infections or trauma.
"This discovery marks a dramatic change in our understanding of how TLE comes about. Previously, it was believed that neurons died after damaging events and that the remaining neurons reorganized with abnormal connections," said Baram, the Danette Shepard Chair in Neurological Studies. "However, in both people and model animals, epilepsy can arise without the apparent death of brain cells. The neurons simply seem to behave in a very abnormal way."
To learn why, Baram's UCI team collaborated with a French group led by Christophe Bernard of the University of Marseille and Inserm. They focused on ion channels, molecules that straddle the boundaries of brain cells and govern how they fire and communicate among themselves.
Specifically, they explored an ion channel called HCN1 which is suppressed in response to brain seizures, injuries and infections that lead to epilepsy hoping to find the long-sought mechanism that triggers epileptic activity in previously normal brain cells.
In their study, which appears online in the Annals of Neurology, the researchers reveal that mechanism: The HCN1 channel gene and about three dozen other important genes are altered by a major cellular repressor called NRSF, which increases after events that give rise to epilepsy.
NRSF proteins work by attaching to the DNA of selected genes and shutting them down, causing neurons to fire abnormally and promoting the development of epilepsy. This was discovered when Baram and her colleagues prevented NRSF from linking to HCN1 and other NRSF-regulated genes, the development of epilepsy was markedly lessened.
This NRSF binding process is an example of epigenetics enduring changes to gene expression without changes to the DNA sequence. Baram said the study is the first to show the significance of epigenetic mechanisms in the formation of epilepsy. The findings also point to NRSF having a larger role in influencing brain activity.
"NRSF operates like a master switch on many genes affecting neuron function," said Shawn McClelland, UCI researcher and study co-author. "And if its levels increase, it can provoke changes lasting for years."
"We're quite excited about this discovery," Baram said. "Understanding how previous brain infections, seizures or injuries can interact with the cellular machinery to cause epilepsy is a crucial step toward designing drugs to prevent the process. We don't want to just treat people with epilepsy. We hope to develop medicines that will prevent epilepsy from occurring and influence the lives of millions of people around the globe."
The founder of UCI's Epilepsy Research Center, Baram is considered the world's leading investigator of the basic neural mechanisms involved in childhood febrile seizures those caused by high fever and how prolonged febrile seizures might lead to the onset of TLE.
Provided by University of California - Irvine
-
Commonplace sugar compound silences seizures
Oct 16, 2006 |
not rated yet |
0
-
Possible link between different forms of epilepsy found
Jun 16, 2008 |
not rated yet |
0
-
Research shows how genetic mutation causes epilepsy in infants
Oct 03, 2007 |
not rated yet |
0
-
Research shows how genetic mutation causes epilepsy in infants
Sep 24, 2007 |
not rated yet |
0
-
Early treatment stops epilepsy in its tracks
Dec 13, 2007 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Persistent sensory experience is good for aging brain
Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. ...
Neuroscience
8 hours ago |
not rated yet |
0
Boundary stops molecule right where it needs to be
A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.
Neuroscience
9 hours ago |
not rated yet |
0
|
Locating ground zero: How the brain's emergency workers find the disaster area
Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. ...
Neuroscience
9 hours ago |
5 / 5 (2) |
0
|
Genetic 'reset switch' enables signaling pathway to induce multiple developmental outcomes for olfactory neurons
Within the nervous system, a handful of signaling pathways modulate development of a cornucopia of different neuronal subtypes. Even small alterations in neuron differentiation pathways can disrupt subsequent ...
Neuroscience
12 hours ago |
not rated yet |
0
The auditory cortex adapts agilely with concentration
The birth of sensory perception on the human cerebral cortex is yet to be fully explained. The different areas on the cortex function in cooperation, and no perception is the outcome of only one area working alone. In his ...
Neuroscience
13 hours ago |
not rated yet |
0
Amino acid consumption associated with how fast cancer cells divide
For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...
'Personality genes' may help account for longevity
"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...
Gene discovery points towards non-hormonal male contraceptive
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Cyber exercise partners help you go the distance: Motivation gains can double
A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation by as much as 100 percent ...
Brentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...